MIP-3 alpha/CCL20 蛋白, Human (CHO)

MIP-3 alpha/CCL20 Protein, Human (CHO) is a CC chemokine that attracts lymphocytes and mild neutrophils by binding to and acting on the chemokine receptor CCR6. It induces intracellular calcium mobilization and mediates cancer, various autoimmune diseases, and antimicrobial effects. MIP-3 alpha/CCL20 Protein, Human (CHO) is a recombinant human CCL20 (A27-M96) expressed by CHO cells^[1].

CCL20，也称为巨噬细胞炎症蛋白3α（MIP-3-α）和肝激活调节趋化因子（LARC），是属于CC趋化因子家族的一种小细胞因子，位于人类基因组中的2号染色体上。它在胸腺、睾丸、前列腺和肠道中表达水平较低。CCL20 与 CCR6 结合并充当趋化因子受体，并与 CCR6 协同抑制 CD8 T 细胞的功能。CCL20 具有抗菌活性，与炎症性肠病、类风湿性关节炎、牛皮癣等自身免疫性疾病以及肿瘤疾病有关。它可以诱导Treg细胞侵入肿瘤组织，募集树突状细胞促进免疫抑制，并诱导内皮细胞增殖和新内膜形成^[1][2]。

CCL20 (human, 0-50 μg/mL) inhibits B. abortus 2308 with the LD₅₀ (the dose that achieves 50% reduction of CFU) > 50 μg/mL, effects on B. abortus RB51 in a dose-dependent manner with a LD₅₀ of 8.7 μg/mL and demonstrates anti-E. coli activity with a LD₅₀ of 1.5 μg/mL^[3].
CCL20 is up-regulated in human colon adenocarcinoma cell lines stimulated by pro-inflammatory cytokines IL-1α and TNF-α and can function as an NF-κB target gene^[4].

The ED₅₀ is <200 ng/mL as measured by CHO-K1/Gα15/hCCR6 cells (human Gα15 and human CCR6 stably expressed in CHO-K1 cells).

Human

CHO

Tag Free

P78556-1 (A27-M96)

6364  [NCBI]

ASNFDCCLGYTDRILHPKFIVGFTRQLANEGCDINAIIFHTKKKLSVCANPKQTWVKYIVRLLSKKVKNM

Approximately 8 kDa

Greater than 95% as determined by reducing SDS-PAGE.

无菌粉末.

Lyophilized after extensive dialysis against PBS.

<0.2 EU/μg, determined by LAL method.

It is not recommended to reconstitute to a concentration less than 100 μg/mL in ddH₂O. For long term storage it is recommended to add a carrier protein (0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose).

Stored at -20°C for 2 years. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.

Room temperature in continental US; may vary elsewhere.

• [1]. Louis Boafo Kwantwi, et al. Multifaceted roles of CCL20 (C-C motif chemokine ligand 20): mechanisms and communication networks in breast cancer progression. Bioengineered. 2021 Dec;12(1):6923-6934.  [Content Brief]

  [2]. M Baba, et al. Identification of CCR6, the specific receptor for a novel lymphocyte-directed CC chemokine LARC. J Biol Chem. 1997 Jun 6;272(23):14893-8.  [Content Brief]

  [3]. M Soledad Hielpos, et al. CCL20 and Beta-Defensin 2 Production by Human Lung Epithelial Cells and Macrophages in Response to Brucella abortus Infection. PLoS One. 2015 Oct 8;10(10):e0140408.  [Content Brief]

  [4]. A Izadpanah, et al. Regulated MIP-3alpha/CCL20 production by human intestinal epithelium: mechanism for modulating mucosal immunity. Am J Physiol Gastrointest Liver Physiol. 2001 Apr;280(4):G710-9.  [Content Brief]